share_log
Benzinga ·  Apr 29 08:06
Sight Sciences Announces $34M Patent Infringement Verdict Against Alcon And Its Hydrus Microstent For Microinvasive Glaucoma Surgery; Monetary Damages Comprised Of $5.5M In Lost Profits And $28.5M In Royalty Damages For Sales Of The Hydrus Microstent For The Period From Its Commercial Launch Through Trial
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment